Ou, S. I., Govindan, R., Eaton, K. D., Otterson, G. A., Gutierrez, M., Mita, A. C., . . . Robert, F. (2016). Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer.
Citación estilo ChicagoOu, Sai‐Hong Ignatius, et al. Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer. 2016.
Cita MLAOu, Sai‐Hong Ignatius, et al. Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer. 2016.
Warning: These citations may not always be 100% accurate.